145 2.2 Controlled Substances  ................................ ................................ ............  145 3.0 Analysis  ................................ ................................ ................................ ................  145 3.1 Analytical Testing  for Anti-Doping Organizations  (Signatories  or WADA ) ... 146 3.2 Analytical Testing  for non -Signatories  ................................ ......................  146 3.3 Clinical or Forensic Analysis  ................................ ................................ .... 146    ISL – January 2021                            3.4 Other Analytical Activities  ................................ ................................ ........  146 3.5 Sharing of Knowledge  ................................ ................................ .............  147 4.0 Duty to Preserve the Integrity of the World Anti -Doping Program and to Avoid any Detrimental Conduct  ................................ ................................ .............................  147 5.0 Breach and Enforceability  ................................ ................................ ......................  148 ISL ANNEX B – ACCREDITATION REQUIREMENTS FOR MAJOR EVENTS  ....................  149 1.0 Major  Event  Analytical Testing  in the Laboratory Facilities  ................................ ...... 149 1.1 Participation in WADA  Assessment(s)  ................................ .....................  149 1.2 Participation in the WADA  EQAS  ................................ .............................  152 1.3 Pre-Event  Report  ................................ ................................ ....................  152 1.4 Additional Professional Liability Insurance Coverage  ................................  153 1.5 “B” Confirmation  ................................ ................................ .....................  153 1.6 Documentation and Reporting  ................................ ................................ .